In a sealed order that issued on June 11, the Court granted a permanent injunction in favor of Regeneron against Mylan/Biocon in the pending aflibercept BPCIA litigation. … By: Goodwin
Previous Story
Permanent Injunction Issued Preventing Launch of EYLEA® Biosimilar Yesafili™
Next Story
Understanding Director Vidal’s Impact on Inter Partes Review Procedures
